Autolus Therapeutics PLC
NASDAQ:AUTL
Autolus Therapeutics PLC
NASDAQ:AUTL
Price:
1.21
USD
-6.2%
Market Closed
Market Cap:
$322m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
UK |
|
F
|
Fujian Supertch Advanced Material Co Ltd
SSE:688398
|
CN |
|
Tianjin Hi-Tech Development Co Ltd
SSE:600082
|
CN |
|
Cielo SA
BOVESPA:CIEL3
|
BR |
|
F
|
Fibocom Wireless Inc
SZSE:300638
|
CN |
Balance Sheet
Balance Sheet Decomposition
Autolus Therapeutics PLC
Autolus Therapeutics PLC
Balance Sheet Decomposition is not available for
Autolus Therapeutics PLC
Autolus Therapeutics PLC
Balance Sheet
Autolus Therapeutics PLC
Autolus Therapeutics PLC
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
218
|
211
|
153
|
310
|
382
|
240
|
227
|
|
| Cash |
218
|
211
|
153
|
310
|
382
|
240
|
227
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
361
|
|
| Total Receivables |
13
|
31
|
30
|
26
|
29
|
25
|
48
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
29
|
24
|
46
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Other Current Assets |
2
|
8
|
14
|
10
|
14
|
11
|
21
|
|
| Total Current Assets |
233
|
249
|
197
|
347
|
426
|
275
|
661
|
|
| PP&E Net |
20
|
52
|
90
|
52
|
58
|
96
|
105
|
|
| PP&E Gross |
20
|
52
|
90
|
52
|
58
|
96
|
105
|
|
| Accumulated Depreciation |
4
|
9
|
15
|
23
|
28
|
29
|
35
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
12
|
|
| Other Long-Term Assets |
1
|
3
|
7
|
6
|
6
|
4
|
4
|
|
| Total Assets |
254
N/A
|
304
+19%
|
294
-3%
|
406
+38%
|
490
+21%
|
375
-23%
|
783
+109%
|
|
| Liabilities | ||||||||
| Accounts Payable |
2
|
1
|
2
|
0
|
1
|
0
|
2
|
|
| Accrued Liabilities |
18
|
23
|
31
|
28
|
45
|
45
|
55
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
1
|
1
|
0
|
0
|
1
|
4
|
|
| Total Current Liabilities |
21
|
25
|
34
|
29
|
46
|
45
|
61
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
171
|
245
|
|
| Other Liabilities |
1
|
24
|
51
|
64
|
145
|
48
|
50
|
|
| Total Liabilities |
22
N/A
|
49
+125%
|
84
+73%
|
92
+10%
|
192
+108%
|
264
+38%
|
355
+35%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
113
|
237
|
379
|
521
|
670
|
879
|
1 099
|
|
| Additional Paid In Capital |
361
|
501
|
595
|
843
|
1 008
|
1 019
|
1 556
|
|
| Other Equity |
16
|
9
|
6
|
9
|
39
|
29
|
29
|
|
| Total Equity |
233
N/A
|
255
+10%
|
210
-18%
|
313
+49%
|
299
-5%
|
111
-63%
|
427
+283%
|
|
| Total Liabilities & Equity |
254
N/A
|
304
+19%
|
294
-3%
|
406
+38%
|
490
+21%
|
375
-23%
|
783
+109%
|
|
Switch to:
Switch to:
See Also
Discover More
